• After the Covid pandemic, we have resumed stem cell treatments. Appropriate sterility and great care in sanitisation is undertaken as usual. If you are unwell with a cough cold or respiratory symptoms it is best to postpone your procedure.

Neurology Library

Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo.

150 150 NZ Stem Cell Treatment Centre

2009 Sep;110(5):1674-84 Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. Lanza C, Morando S, Voci A, Canesi L, Principato MC, Serpero LD, Mancardi G, Uccelli A, Vergani L Abstract Experimental autoimmune encephalomyelitis (EAE), an animal model for human multiple sclerosis, is characterized by demyelination, inflammation and neurodegeneration of CNS in…

read more

Stem cell-based cell therapy in neurological diseases: a review.

150 150 NZ Stem Cell Treatment Centre

2009 Aug 1;87(10):2183-200. Stem cell-based cell therapy in neurological diseases: a review. Kim SU, de Vellis J. Division of Neurology, Department of Medicine, UBC Hospital, University of British Columbia, Vancouver, British Columbia, Canada. sukim@interchange.ubc.ca Abstract Human neurological disorders such as Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, multiple sclerosis (MS), stroke, and…

read more

Regeneration and repair in multiple sclerosis: the role of cell transplantation.

150 150 NZ Stem Cell Treatment Centre

2009 Jun 12; 456(3) : 101-6. Epub 2009 Jan 17. Regeneration and repair in multiple sclerosis: the role of cell transplantation. Pluchino S, Zanotti L, Brini E, Ferrari S, Martino G. Neuroimmunology Unit and Institute of Experimental Neurology (INSpe), DIBIT-San Raffaele Scientific Institute, via Olgettina 58, 20123 Milano, Italy. Abstract Physiological (spontaneous) and reactive (reparative)…

read more

Multiple sclerosis: Hematopoietic stem cell transplantation: hope and hype.

150 150 NZ Stem Cell Treatment Centre

2009 Jun;5(6):300-2 Multiple sclerosis: Hematopoietic stem cell transplantation: hope and hype. Stangel M Abstract A trial of autologous hematopoietic stem cell transplantation to treat multiple sclerosis has yielded promising results, generating considerable interest within both the clinical literature and the mainstream press.the findings should, however, be interpreted with some caution, and larger, randomized trials will…

read more

Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis.

150 150 NZ Stem Cell Treatment Centre

2009; 7:29 Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. Riordan NH, Ichim TE, Min WP, Wang H, Solano F, Lara F, Alfaro M, Rodriguez JP, Harman RJ, Patel AN, Murphy MP, Lee RR, Minev B Abstract The stromal vascular fraction (SVF) of adipose tissue is known to contain mesenchymal stem cells (MSC),…

read more

Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies.

150 150 NZ Stem Cell Treatment Centre

2008 Dec; 2(4) : 699-705 Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies. Greco SJ, Rameshwar P Abstract The therapeutic utilization of stem cells has been ongoing for several decades, principally in the form of bone marrow (BM) transplants to treat various hematological disorders and other immune-related diseases. More recently,…

read more

The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience.

150 150 NZ Stem Cell Treatment Centre

2008 Nov; 110(9) : 889-96. Epub 2008 Mar 28. The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience. Karussis D, Kassis I. Department of Neurology, Laboratory of Neuroimmunology, Agnes-Ginges Center for Neurogenetics, Hadassah-Hebrew University Hospital, Ein-Karem, Jerusalem, Israel. karus@cc.huji.ac.il Abstract The reported neurodegeneration process in multiple sclerosis may explain…

read more

NeHuman neural stem cells genetically modified for brain repair in neurological disorders.

150 150 NZ Stem Cell Treatment Centre

2004 Sep; 24(3) : 159-71. Human neural stem cells genetically modified for brain repair in neurological disorders. Kim SU. Brain Disease Research Center, Ajou University School of Medicine, Suwon, Korea. sukim@ajou.ac.kr Abstract Existence of multipotent neural stem cells (NSC) has been known in developing or adult mammalian CNS, including humans. NSC have the capacity to…

read more

Stem cells to treat muscular dystrophies – where are we?

150 150 NZ Stem Cell Treatment Centre

2011 Jan;21(1):4-12. Epub 2010 Nov 4. Stem cells to treat muscular dystrophies – where are we? Meng J, Muntoni F, Morgan JE. The Dubowitz Neuromuscular Centre, UCL Institute of Child Health, 30 Guilford Street, London WC1N 1EH, United Kingdom. Abstract The muscular dystrophies are inherited disorders characterised by progressive muscle wasting and weakness. Stem cell…

read more

Splice modification to restore functional dystrophin synthesis in Duchenne muscular dystrophy.

150 150 NZ Stem Cell Treatment Centre

2010;16(8):988-1001 Splice modification to restore functional dystrophin synthesis in Duchenne muscular dystrophy. Wilton SD, Fletcher S Abstract In little more than a decade, induced exon skipping as a therapy to treat Duchenne muscular dystrophy (DMD) has progressed from a concept tested in vitro, to pre-clinical evaluation in mouse and dog models, and recent completion of…

read more